Skip to main content

Month: September 2020

Vranken-Pommery Monopole – Résultat du 1er semestre 2020 : 64,3 M€ Résultat Net semestriel stable

Communiqué financierChiffre d’affaires 1er semestre 2020 : 64,3 M€Résultat Net semestriel stableReims, le 10 septembre 2020Le Conseil d’Administration de Vranken-Pommery Monopole s’est réuni le 10 septembre 2020 sous la Présidence de Monsieur Paul-François Vranken, et en présence des Commissaires aux Comptes, pour arrêter les comptes du Groupe pour le premier semestre 2020.Chiffre d’affairesConséquence des mesures de confinement adoptées partout dans le monde, parmi lesquelles la fermeture des hôtels, cafés, restaurants, l’arrêt de l’événementiel, la forte limitation des vols internationaux et des ventes en Duty-Free, le chiffre d’affaires consolidé du groupe pour le premier semestre 2020 s’établit à 64,3 M€, en retrait de 26,1%. Pour autant, il faut savoir que :L’impact négatif des ventes interprofessionnelles de 4 M€ par rapport au...

Continue reading

Le fonds Canoe EIT Income Fund annonce la distribution pour le mois de septembre 2020

CALGARY, Alberta, 10 sept. 2020 (GLOBE NEWSWIRE) — Le fonds Canoe EIT Income Fund (le « fonds ») [Bourse de Toronto : EIT.UN] annonce une distribution de 0,10 $ par part en septembre 2020. La distribution sera payée le 15 octobre 2020 aux porteurs de parts inscrits le 22 septembre 2020. La date ex-distribution connexe est le 21 septembre 2020.À propos du fonds Canoe EIT Income FundLe fonds Canoe EIT Income Fund est l’un des fonds de placement à capital fixe les plus importants au Canada; il vise à maximiser les distributions mensuelles et l’appréciation du capital en investissant dans un portefeuille largement diversifié de titres de haute qualité. Coté à la Bourse de Toronto sous le symbole EIT.UN, le fonds est activement géré par Robert Taylor, vice-président principal et gestionnaire de portefeuille de Canoe Financial.À propos...

Continue reading

Opthea Appoints US-Based Non-Executive Director

MELBOURNE, Australia, Sept. 10, 2020 (GLOBE NEWSWIRE) — The directors of Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing a novel therapy to treat highly prevalent and progressive retinal diseases, are pleased to announce the appointment of Mr Daniel Spiegelman as an independent Non-Executive Director, who will also serve as Chair of the Company’s Audit and Risk Committee, effective from September 10, 2020.  Mr Spiegelman is a respected and credentialed figure in the biotechnology industry who has provided strategic financial management and insight to a number of life science companies during his career. Most recently, Mr Spiegelman served as the Executive Vice President, Chief Financial Officer of BioMarin Pharmaceutical from May 2012 to January 2020. He is currently interim CEO of Recardia Therapeutics...

Continue reading

Esker :

Lyon, le 10 septembre 2020                                                                                                                                                                                                           Résultats semestriels 2020Résilience et poursuite des plans de développement *Comptes établis selon les normes comptables françaises (CRC 99-02) et non auditésUne activité résiliente malgré la pandémieLe chiffre d’affaires du premier semestre 2020 progresse de plus de 8%, tiré par le succès continu des solutions Cloud (+11%) qui représentent 92% de l’activité.Cette performance combine deux trimestres fortement contrastés. Malgré le déclenchement des mesures de confinement dans plusieurs pays au cours du mois de mars, le premier trimestre 2020 a confirmé la dynamique de croissance d’Esker, démontrée depuis de nombreuses...

Continue reading

Circuit Breaker Market to Exhibit 6.6% CAGR by 2027 Backed by Increasing Demand for Reliable Power Supply, states Fortune Business Insights™

Pune, Sept. 10, 2020 (GLOBE NEWSWIRE) — The global circuit breaker market is expected to experience a considerable growth by exhibiting a CAGR of 6.6% between 2020 and 2027. The growth is attributable to the increasing focus on secured and reliable power supply that is driving the demand for these breakers across the globe. Fortune Business Insights, in its latest report, titled, “Circuit Breaker Market Size, Share & COVID-19 Impact Analysis, By Voltage (Low, Medium, and High), By Installation (Indoor and Outdoor), By End User, By Rated Voltage, and Regional Forecast, 2020-2027,” mentions that the market stood at USD 16.04 billion in 2019 and is projected to reach USD 25.85 billion by 2027.Click here to get the short-term and long-term impact of COVID-19 on this market.Please visit: https://www.fortunebusinessinsights.com/industry-reports/circuit-breaker-market-100765COVID-19...

Continue reading

Nombre total de droits de vote et d’actions au 31 août 2020

Déclaration relative au nombre total de droits de vote et d’actions prévues par les articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers      (1)   En raison d’auto détention par contrat d’animation Pièce jointe2020-8-31_AKWEL_DeclarationMensuelle_NbActionDroitsdeVote

Continue reading

Capital Digestive Care Partners with Peninsula Gastroenterology Associates, Expanding Presence in Maryland

Silver Spring, MD, Sept. 10, 2020 (GLOBE NEWSWIRE) — Capital Digestive Care, the largest private gastroenterology practice in the Mid-Atlantic, is pleased to announce a partnership with independent gastroenterology practice Peninsula Gastroenterology Associates (PGA) of Delmar, Maryland. The partnership, effective September 1, 2020, expands Capital Digestive Care’s geographic reach to the Eastern Shore area of the Mid-Atlantic, meeting the needs of patients and physician groups in this underserved area.PGA has been treating Southern Maryland and Southern Delaware residents since 1975. The practice’s six providers, including four board-certified gastroenterologists and two advanced care practitioners, are experts in the evaluation and treatment of digestive and liver diseases and are committed to providing compassionate, high-quality,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.